← All companies

Amgen (AMGN)

Hold Current rating · 2 reports

2026-05-01

Hold Recap: Q1 2026

Amgen's Beat-and-Raise Gets Sold: Low-Quality Composition and Two Fresh Overhangs Outweigh a Cheaper Stock
2026-02-04

Hold Recap: Q4 2025

Amgen's Double Beat and Above-Street 2026 Guide Reprice the Stock 8%; MariTide Remains the Whole Ballgame